TH-009(Thabor therapeutics)

N/A

Report date: 2025/03/28 16:27:47

Base Information

Drug NameTH-009(Thabor therapeutics)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAnti-Anterior Gradient 2, Protein Disulphide Isomerase Family Member
TargetsAnterior Gradient 2, Protein Disulphide Isomerase Family Member
Therapy Area/IndicationsInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThabor Therapeutics SAS
China Registration ClassN/A

Develop Information

Active CompaniesThabor Therapeutics SAS
Inactive CompaniesN/A
Active IndicationsInflammatory Bowel Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A